Rising with cardio-oncology: Clinical considerations of cardiotoxicity with select anticancer drug therapies
Strategies to mitigate the cardiotoxicity of anticancer therapies and identify patients who may require time-sensitive interventions or long-term follow-up represent promising opportunities to improve the quality and safety of care in the emerging field of cardio-oncology pharmacy.
Authors
- Katelynn Tran (ORCID: https://orcid.org/0000-0002-0593-8060)
- Clement Chung (ORCID: https://orcid.org/0000-0002-7189-6612)
Institutions
- Houston Methodist (US)
- Methodist Hospital (US)
- Methodist West Hospital (US)
- Samaritan Health Services (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-10-18
- DOI
- https://doi.org/10.1093/ajhp/zxaf282
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39